REPLAY THERAPEUTICS
Replay Therapeutics develops a hypoimmunogenic iPSC therapeutic platform and redefines gene therapy and genome editing.
REPLAY THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Health Care
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.replay.bio
Status:
Active
Total Funding:
0
Similar Organizations
AddGraft Therapeutics
AddGraft Therapeutics develops gene delivery platform that cures substance abuse disorder through a one-time treatment.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
RegeneMed
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.
Xcell Therapeutics
Xcell Therapeutics develops and produces serum-free chemically defined media.
Yuanjian Youke
Yuanjian Youke is an integrated CDMO service provider for cell and gene therapy industry.
Current Employees Featured
Founder
Investors List
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Replay Therapeutics
Official Site Inspections
http://www.replay.bio
- Host name: 104.21.80.1
- IP address: 104.21.80.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Replay Therapeutics"
Replay
Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseasesSee details»
Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine.See details»
Replay Launches with $55 Million Seed to Reprogram …
Jul 25, 2022 · San Diego, California and London, UK, 25 July 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced its launch with $55 million in seed financing.See details»
Replay - Crunchbase Company Profile & Funding
Jul 25, 2022 · Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. Where is Replay's …See details»
Replay - LinkedIn
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.See details»
Replay Launches with $55 Million Seed to Reprogram Biology by …
Jul 25, 2022 · San Diego, California and London, UK, 25 July 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced its …See details»
Management | Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine.See details»
Replay Launches With $55M Seed Round - San Diego Business …
Aug 12, 2022 · Replay, a biotech firm with dual headquarters in San Diego and London, has emerged from stealth with $55 million in seed financing to advance its platform for writing …See details»
Replay Overview | SignalHire Company Profile
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.See details»
Replay Launches with $55 Million Seed to Transform …
Jul 25, 2022 · Replay, a company built on a portfolio of interconnected next-generation cutting-edge technology platforms that aim to solve critical problems in genomic medicine, today announced its launch with...See details»
Replay receives $1.5 million grant for its hypoimmunogenic
Nov 28, 2022 · Replay’s uCellâ„¢ platform is an off-the-shelf, genomically rewritten, hypoimmunogenic technology that allows allogeneic donor-derived primary cells and iPSCs …See details»
Replay Company Profile - Office Locations, Competitors, Revenue …
Replay is a company developing an enzyme writing product platform for reprogramming biology by writing and delivering big DNA constructs. It offers genomic products, synthetic gene …See details»
Replay Launches with $55 Million Seed to Reprogram Biology
Jul 25, 2022 · San Diego, California and London, UK, 25 July 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced its …See details»
Replay launches to reprogram biology by writing and delivering …
Jul 25, 2022 · Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by …See details»
Founders | Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine.See details»
Replay establishes distinguished Scientific Advisory Board
Oct 17, 2022 · San Diego, California and London, UK, October 17, 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced …See details»
News - Replay
Oct 31, 2022 · Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseasesSee details»
Levels of Organization in Biology - Science Notes and Projects
Feb 13, 2024 · From the simplest to the most complex, the levels of organization in biology are: atoms, molecules, macromolecules, cells, tissues, organs, organ systems, organisms, …See details»
Replay establishes distinguished Scientific Advisory Board of …
Oct 17, 2022 · The newly formed SAB will provide input into Replay’s strategy, portfolio of next-generation genomic and cell therapy medicines, and associated technology platforms. The …See details»